Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 189
Filter
Add more filters

Publication year range
1.
Drug Resist Updat ; 66: 100890, 2023 01.
Article in English | MEDLINE | ID: mdl-36455341

ABSTRACT

Drug resistance is well-defined as a serious problem in our living world. To survive, microbes develop defense strategies against antimicrobial drugs. Drugs exhibit less or no effective results against microbes after the emergence of resistance because they are unable to cross the microbial membrane, in order to alter enzymatic systems, and/or upregulate efflux pumps, etc. Drug resistance issues can be addressed effectively if a "Resistance-Proof" or "Resistance-Resistant" antimicrobial agent is developed. This article discusses first the need for resistance-proof drugs, the imminent properties of resistance-proof drugs, current and future research progress in the discovery of resistance-proof antimicrobials, the inherent challenges, and opportunities. A molecule having imminent resistance-proof properties could target microbes efficiently, increase potency, and rule out the possibility of early resistance. This review triggers the scientific community to think about how an upsurge in drug resistance can be averted and emphasizes the discussion on the development of next-generation antimicrobials that will provide a novel effective solution to combat the global problem of drug resistance. Hence, resistance-proof drug development is not just a requirement but rather a compulsion in the drug discovery field so that resistance can be battled effectively. We discuss several properties of resistance-proof drugs which could initiate new ways of thinking about next-generation antimicrobials to resolve the drug resistance problem. This article sheds light on the issues of drug resistance and discusses solutions in terms of the resistance-proof properties of a molecule. In summary, the article is a foundation to break new ground in the development of resistance-proof therapeutics in the field of infection biology.


Subject(s)
Anti-Bacterial Agents , Anti-Infective Agents , Humans , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Drug Resistance , Drug Discovery/methods
2.
Article in English | MEDLINE | ID: mdl-38822156

ABSTRACT

Fruits are a very good source of various nutrients that can boost overall human health. In these days, the recovery of therapeutic compounds from different fruit wastes is trending in research, which might not only minimize the waste problem but also encounter a higher demand for various enzymes that could have antimicrobial properties against infectious diseases. The goal of this review is to focus on the recovery of therapeutic enzymes from fruit wastes and its present-day tendency for utilization. Here we discussed different parts of fruit waste, such as pulp, pomace, seed, kernel, peel, etc., that produce therapeutic enzymes like amylase, cellulose, lipase, laccase, pectinase, etc. These bioactive enzymes are present in different parts of fruit and could be used as therapeutics against various infectious diseases. This article provides a thorough knowledge compilation of therapeutic enzyme isolation from fruit waste on a single platform, distinctly informative, and significant review work on the topic that is envisioned to encourage further research ideas in these areas that are still under-explored. This paper explains the various aspects of enzyme isolation from fruit and vegetable waste and their biotherapeutic potential that could provide new insights into the development of biotherapeutics and attract the attention of researchers to enhance translational research magnitude further.

3.
Brief Bioinform ; 22(4)2021 07 20.
Article in English | MEDLINE | ID: mdl-33313694

ABSTRACT

Billions of people are affected by fungal infection worldwide, which is a major cause of morbidity and mortality in humans. Regardless of development in the field of antifungal therapeutics over the last three decades, multidrug resistance and limited efficacy of available antifungal drugs are very prominent and still a great hurdle in the patient treatment. The current antifungal pipeline is dry, which is needed to be strengthened. Although several strategies have been implemented over time to discover novel promising antifungal leads, but very little emphasis has been given to address the gap of fungal target identification. Undeniably, the need for identifying novel cellular fungal targets is as vital as discovering novel antifungal leads and a structural bioinformatics approach could be an effective strategy in this regard. To address the issue, we have performed in silico screening to identify a few potent multiple targeting ligands and their respective antifungal targets. Thus, we offer a perspective on the phenomena of 'target shortage' and least explored 'multiple targeting' being the most underrated challenges in antifungal drug discovery. 'Structural bioinformatics' could be an effective approach in the recognition of new/innovative antifungal target and identification/development of novel antifungal lead molecule aiming multiple molecular targets of the fungal pathogen.


Subject(s)
Antifungal Agents , Computational Biology , Drug Development , Drug Discovery , Mycoses/drug therapy , Antifungal Agents/chemistry , Antifungal Agents/therapeutic use , Fungi/growth & development , Humans
4.
Microb Pathog ; 175: 105966, 2023 Feb.
Article in English | MEDLINE | ID: mdl-36592641

ABSTRACT

Globally, bacteria are well-known microorganisms for bacterial biofilm infection. Bacterial biofilm has generated antibiotic resistance and led the persistent infection. But new complications arise with a biofilm that bacterial biofilm shows the new association with oncogenesis. Some bacteria have a carcinogenic nature at the chronic infection stage like Salmonella Typhi, Helicobacter pylori. Thus, biofilm has a significant role in oncogenesis. Few pieces of evidence also support that the bacterial biofilm has a potential role to develop oncogenesis in the human body. Bacterial biofilm is responsible to induce chronic inflammation and is the main basis for the oncogenesis process. But bacterial biofilm association with the oncogenesis mechanism is unknown yet. This article focuses on the function of bacterial biofilm in tumor formation and the mechanism that encourages the oncogenesis and provide a possible and interesting hypothesis involved in between biofilm and host oncogenesis progression. The discussed relationship will provide a sound direction in the field of oncology and concept may give an informative direction in diagnosis and treatment. Bacterial biofilm behavior could be significantly linked with cancer cell formation. This article attracts the attention of researchers of the field because biofilm mediated oncogenesis further indicate towards an important issue in human health.


Subject(s)
Bacterial Infections , Biofilms , Humans , Bacteria , Bacterial Infections/drug therapy , Drug Resistance, Microbial , Carcinogenesis , Anti-Bacterial Agents/pharmacology
5.
Nitric Oxide ; 140-141: 41-49, 2023 Nov 01.
Article in English | MEDLINE | ID: mdl-37714296

ABSTRACT

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by behavioral deficits such as abnormalities in communication, social interaction, anxiety, and repetitive behavior. We have recently shown that the Shank3 mutation in mice representing a model of ASD causes excessive nitric oxide (NO) levels and aberrant protein S-nitrosylation. Further, 10-day daily injections of 7-NI, a neuronal nitric oxide synthase inhibitor, into Shank3Δ4-22 and Cntnap2(-/-) mutant mice (models of ASD) at a dose of 80 mg/kg reversed the manifestations of ASD phenotype. In this study, we proposed an extended release of 7-NI using a novel drug system. Importantly, unlike the intraperitoneal injections, our new preparation of poly (sebacic acid-co-ricinoleic acid) (PSARA) gel containing 7-NI was injected subcutaneously into the mutant mice only once. The animals underwent behavioral testing starting from day 3 post-injection. It should be noted that the developed PSARA gel formulation allowed a slow release of 7-NI maintaining the plasma level of the drug at ∼45 µg/ml/day. Further, we observed improved memory and social interaction and reduced anxiety-like behavior in Shank3 mutant mice. This was accompanied by a reduction in 3-nitrotyrosine levels (an indicator of nitrative/nitrosative stress) in plasma. Overall, we suggest that our single-dose formulation of PSARA gel is very efficient in rendering a therapeutic effect of 7-NI for at least 10 days. This approach may provide in the future a rational design of an effective ASD treatment using 7-NI and its clinical translation.


Subject(s)
Autism Spectrum Disorder , Autistic Disorder , Mice , Animals , Autistic Disorder/genetics , Autism Spectrum Disorder/drug therapy , Autism Spectrum Disorder/genetics , Autism Spectrum Disorder/metabolism , Indazoles , Behavior, Animal , Disease Models, Animal , Microfilament Proteins , Nerve Tissue Proteins
6.
Environ Res ; 216(Pt 2): 114527, 2023 01 01.
Article in English | MEDLINE | ID: mdl-36265607

ABSTRACT

Biochar is known for the improvement of soil health, fertility, crop productivity, and quality in many agro-ecosystems globally, but information regarding fodder yield, quality, and soil microbial activity responses to biochar application remains very limited. The objective of this study was to prepare biochar from invasive weeds, i.e., Parthenium hysterophorus L. and Lantana camara L., and use it as a soil amendment along with inorganic fertilizers for oats (Avena sativa L.) growth, fodder yield, quality, and soil microbial activities in a two-year pot experiment. Treatments were comprised of control, 100% RDF (Recommended dose of fertilizers), 75% RDF along with three doses (2.5, 5.0, and 10 t/ha) of Parthenium hysterophorus L. biochar (PB) and Lantana camara L. biochar (LB), PB (10 t/ha), and LB (10 t/ha). Results showed that application of 75% RDF along with 10 t/ha LB gave significantly higher green (∼8%) and dry (∼7.8%) fodder yield and crude protein (∼6%) and decreased acid detergent fibre (ADF) and neutral detergent fibre (NDF) by 5.70 and 6.04% as compared to the 100% RDF treatment. The same treatment had a significantly higher population of bacteria (7.33 × 108 colony forming unit (CFU)/g soil), alkaline phosphatase activity (19.56 µg pNP/g soil/h), microbial biomass carbon (156.67 µg/g soil) and dehydrogenase activity (12.59 µg TPF/g/24 h), whereas the maximum fungal population (13.33 × 104 CFU/g soil) and acid phosphatase activity (14.45 µg pNP/g soil/h) were found in 75% RDF along with 10 t/ha PB and control treatment, respectively. This study concluded that application of invasive weed biochar along with inorganic fertilizers can benefit fodder yield and quality of oats by increasing plant height and number of tillers directly and by improving nutrient availability and water holding capacity (WHC) of soil indirectly, besides improving soil health. The findings from this study will provide a potential strategy for invasive weed management.


Subject(s)
Fertilizers , Soil , Plant Weeds , Avena , Ecosystem , Detergents , Agriculture/methods , Edible Grain , Animal Feed
7.
Curr Genomics ; 24(2): 100-109, 2023 Oct 27.
Article in English | MEDLINE | ID: mdl-37994324

ABSTRACT

Background: Salmonella typhi biofilm confers a serious public health issue for lengthy periods and the rise in antibiotic resistance and death rate. Biofilm generation has rendered even the most potent antibiotics ineffective in controlling the illness, and the S. typhi outbreak has turned into a fatal disease typhoid. S. typhi infection has also been connected to other deadly illnesses, such as a gall bladder cancer. The virulence of this disease is due to the interaction of numerous genes and proteins of S. typhi. Objective: The study aimed to identify a cascade of target proteins in S. typhi biofilm condition with the help of genomic data mining and protein-protein interaction analysis. Methods: The goal of this study was to notice some important pharmacological targets in S. typhi. using genomic data mining, and protein-protein interaction approaches were used so that new drugs could be developed to combat the disease. Results: In this study, we identified 15 potential target proteins that are critical for S. typhi biofilm growth and maturation. Three proteins, CsgD, AdrA, and BcsA, were deciphered with their significant role in the synthesis of cellulose, a critical component of biofilm's extracellular matrix. The CsgD protein was also shown to have high interconnectedness and strong interactions with other important target proteins of S. typhi. As a result, it has been concluded that CsgD is involved in a range of activities, including cellulose synthesis, bacterial pathogenicity, quorum sensing, and bacterial virulence. Conclusion: All identified targets in this study possess hydrophobic properties, and their cellular localization offered proof of a potent therapeutic target. Overall results of this study, drug target shortage in S. typhi is also spotlighted, and we believe that obtained result could be useful for the design and development of some potent anti-salmonella agents for typhoid fever in the future.

8.
Ecotoxicology ; 32(5): 606-617, 2023 Jul.
Article in English | MEDLINE | ID: mdl-37233842

ABSTRACT

Soil is the most widespread area for the co-occurrence of two or more numbers of contaminants. Therefore, toxicity assessments based on contaminants mixture are urgently required to assess their combined impacts on soil enzymes. In the present study, the median effect plot and the combination index isobologram were studied to evaluate the dose-response curve for individual and interactive impacts of chlorpyrifos (Chl), cypermethrin (Cyp), and arsenic (As) on soil dehydrogenase, a potential marker of soil health. Along with these methods, a two-way ANOVA was also tested and the results showed significant changes with respect to different treatments. The results also showed that the Dm value increases in the order of As0.25 fa level. However, Chl + Cyp unveiled a synergistic impact over soil dehydrogenase on day 30th. The overall impact of applied chemicals on dehydrogenase activity was contributed by bioavailability and the nature of toxicological interactions between them. This study would be one of the exclusive studies for the agricultural sector to predict the potential risk associated with the co-existence of these or similar contaminants in the terrestrial environment.


Subject(s)
Arsenic , Chlorpyrifos , Insecticides , Soil Pollutants , Chlorpyrifos/toxicity , Insecticides/toxicity , Arsenic/toxicity , Soil , Oxidoreductases , Soil Pollutants/toxicity
9.
Symbiosis ; : 1-15, 2023 Jun 08.
Article in English | MEDLINE | ID: mdl-37360552

ABSTRACT

The synthesis of secondary metabolites is a constantly functioning metabolic pathway in all living systems. Secondary metabolites can be broken down into numerous classes, including alkaloids, coumarins, flavonoids, lignans, saponins, terpenes, quinones, xanthones, and others. However, animals lack the routes of synthesis of these compounds, while plants, fungi, and bacteria all synthesize them. The primary function of bioactive metabolites (BM) synthesized from endophytic fungi (EF) is to make the host plants resistant to pathogens. EF is a group of fungal communities that colonize host tissues' intracellular or intercellular spaces. EF serves as a storehouse of the above-mentioned bioactive metabolites, providing beneficial effects to their hosts. BM of EF could be promising candidates for anti-cancer, anti-malarial, anti-tuberculosis, antiviral, anti-inflammatory, etc. because EF is regarded as an unexploited and untapped source of novel BM for effective drug candidates. Due to the emergence of drug resistance, there is an urgent need to search for new bioactive compounds that combat resistance. This article summarizes the production of BM from EF, high throughput methods for analysis, and their pharmaceutical application. The emphasis is on the diversity of metabolic products from EF, yield, method of purification/characterization, and various functions/activities of EF. Discussed information led to the development of new drugs and food additives that were more effective in the treatment of disease. This review shed light on the pharmacological potential of the fungal bioactive metabolites and emphasizes to exploit them in the future for therapeutic purposes.

10.
Cell Tissue Bank ; 24(1): 211-220, 2023 Mar.
Article in English | MEDLINE | ID: mdl-35849224

ABSTRACT

Chronic wounds are a persistent burden for medical professionals. Despite developments and advancements in treatment, these wounds do not heal completely. Mesenchymal stem cells (MSCs) are the epicenter of regenerative medicine that have shown promising results in chronic wound regeneration. Autologous peripheral blood-derived MSCs (PB-MSCs) are comparatively new in wound healing treatment, bone-marrow-derived MSCs (BM-MSCs), and adipose-derived stem cells (ADSCs) are commonly being practiced. In the present study, PB-MSCs treatment was given to chronic wound patients. Various biochemical parameters like random blood glucose, serum urea, serum creatinine, bilirubin (total and direct), Aspartate Aminotransferase (AST), Alanine Aminotransferase (ALT), total protein, albumin levels, and association of other factors/conditions such as age, sex, addiction of drug/alcohol were also evaluated/compared with complete and without complete healing. The wound area of the ulcer was found to be significantly reduced and the wound was healthier after the treatment. These biochemical parameters could be certainly utilized as biomarkers to anticipate the risk of chronic wounds. These findings may contribute to the development of better wound care treatment strategies and drug discovery in the field of regenerative medicine.


Subject(s)
Mesenchymal Stem Cell Transplantation , Mesenchymal Stem Cells , Humans , Mesenchymal Stem Cell Transplantation/methods , Wound Healing
11.
Int J Mol Sci ; 24(14)2023 Jul 21.
Article in English | MEDLINE | ID: mdl-37511480

ABSTRACT

The development of paclitaxel-loaded polymeric nanoparticles for the treatment of brain tumors was investigated. Poly(lactide-glycolide) (PLGA) nanoparticles containing 10% w/w paclitaxel with a particle size of 216 nm were administered through intranasal and intravenous routes to male Sprague-Dawley rats at a dose of 5 mg/kg. Both routes of administration showed appreciable accumulation of paclitaxel in brain tissue, liver, and kidney without any sign of toxicity. The anti-proliferative effect of the nanoparticles on glioblastoma tumor cells was comparable to that of free paclitaxel.


Subject(s)
Glioblastoma , Nanoparticles , Paclitaxel , Polylactic Acid-Polyglycolic Acid Copolymer , Polylactic Acid-Polyglycolic Acid Copolymer/chemistry , Paclitaxel/administration & dosage , Paclitaxel/chemistry , Nanoparticles/chemistry , Humans , Glioblastoma/drug therapy , Administration, Intranasal , Nasal Absorption , Cell Line, Tumor , Animals , Rats , Blood-Brain Barrier
12.
World J Microbiol Biotechnol ; 39(6): 164, 2023 Apr 18.
Article in English | MEDLINE | ID: mdl-37069369

ABSTRACT

Underestimating fungal infections led to a gap in the development of antifungal medication. However, rising rates of morbidity and mortality with fungal infection have revealed an alarming rise in antifungal resistance also. Due to the eukaryotic properties of fungi and the close evolutionary similarity between fungal cells and human hosts, therapeutic targeting of Candida infections is troublesome, along with the development of resistance. The discovery of new antifungals is so far behind schedule that the antifungal pipeline is nearly empty. Previously, we have reported the activity and susceptibility of Sodium lignosulfonate (LIG) against C. albicans. In this work, we have established the mechanistic actions of LIG's activity. We performed flow cytometric analysis for membrane integrity, ergosterol binding assay, crystal violet assay, and membrane leakage assay to analyze quantitatively that the C. albicans membrane is being disrupted in response to LIG. Electron microscopic analysis with SEM and TEM confirmed changes in Candida cellular morphology and membrane perturbation respectively. These findings indicated that LIG causes cell membrane damage in C. albicans. This knowledge about LIG's mechanism of action against C. albicans could be used to explore it further as a lead antifungal molecule to develop it as a potent candidate for antifungal therapeutics in the future.


Subject(s)
Antifungal Agents , Candida albicans , Lignin , Lignin/analogs & derivatives , Candida albicans/cytology , Candida albicans/drug effects , Antifungal Agents/pharmacology , Cell Membrane/chemistry , Cell Membrane/drug effects
13.
Microb Pathog ; 163: 105383, 2022 Feb.
Article in English | MEDLINE | ID: mdl-34974120

ABSTRACT

Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the gastrointestinal system. Previously, it is considered the disease of the western world but now the incidence and prevalence of IBD are increasing globally with urbanization and modernization. Additionally, the major problem is the highest incidence of IBD among children and adolescents. The precise etiology of IBD is unknown and there is no cure for IBD, which is also the reason for increasing the number of cases worldwide. The IBD is a complex interplay of environment, immune system, and microbiota in a genetically susceptible host. Among these factors, the alteration in intestinal microbiota has been detected in IBD patients. The bacterial species associated with IBD include Mycobacterium paratuberculosis, adherent-invasive E. coli (AIEC), Helicobacter pylori, and Campylobacter concisus. Moreover, the efficacy of antibiotics and probiotics further suggests the role of microbes in IBD. However, no study confirmed the bacterial species as a cause of IBD as per Koch's postulates. Thus, still controversies exist regarding the role of microbes in IBD. Therefore, this paper aims to review the current literature to evaluate the role of microbes in IBD that would be a useful inventory of researchers working in this area.


Subject(s)
Gastrointestinal Microbiome , Inflammatory Bowel Diseases , Microbiota , Probiotics , Adolescent , Animals , Child , Escherichia coli , Humans
14.
Biomacromolecules ; 23(4): 1672-1679, 2022 04 11.
Article in English | MEDLINE | ID: mdl-35357807

ABSTRACT

Biodegradable polymer clips as multidimensional soft tissue biopsy markers were developed with better biocompatibility and imaging features. Unlike the commercially available metallic biopsy markers, the developed polymer clips are temporary implants with similar efficacies as metal markers in imaging and detection and get absorbed within the body with time. Herein, we evaluate the degradation rate of three resorbable polymer-based marker compounds in an in vivo murine model. Three polymers, abbreviated as Polymer A (PLGA poly(lactic-co-glycolic acid)50:50), Polymer B (PLGA (poly(lactic-co-glycolic acid)) 75:25), and Polymer C (polycaprolactone (PCL)), mixed with 20% lipiodol and 0.2% iron oxide and a control polymer were implanted into nine mice, followed by CT and MRI imaging. Images were evaluated for conspicuity. Specimens were examined for tissue analysis of iodine and iron contents. Significant differences in polymer resorption and visualization on CT were noted, particularly at 8 weeks (p < 0.027). Polymers A, B, and C were visible by CT at 4, 6, and 8 weeks, respectively. All marker locations were detected on MRI (T1 and SWI) after 24 weeks, with tattooing of the surrounding soft tissue by iron deposits. CT and MR visible polymer markers can be constructed to possess variable resorption, with stability ranging between 4 and 14 weeks post placement, making this approach suitable for distinct clinical scenarios with varying time points.


Subject(s)
Polyglycolic Acid , Prostheses and Implants , Animals , Disease Models, Animal , Iron , Magnetic Resonance Imaging , Mice
15.
Crit Rev Food Sci Nutr ; 62(30): 8249-8264, 2022.
Article in English | MEDLINE | ID: mdl-34024191

ABSTRACT

Candidiasis (e.g., oral, gastrointestinal, vaginal, urinary tract, systemic) is a worldwide growing problem, since antifungal resistance and immunosuppression states are rising. To address this problem, very few drugs are available for the treatment of Candida spp. infections. Therefore, novel therapeutic strategies are urgently required. Probiotics have been proposed for the prevention and treatment of bacterial infections due to their safety record and efficacy, however, little is still known about their potential role regarding fungal infections. The purpose of this review is to present an updated summary of the evidence of the antifungal effects of probiotics along with a discussion of their potential use as an alternative/complementary therapy against Candida spp. infections. Thus, we performed a literature search using appropriate keywords ("Probiotic + Candida", "Candidiasis treatment", and "Probiotic + candidiasis") to retrieve relevant studies (both preclinical and clinical) with special emphasis on the works published in the last 5 years. An increasing amount of evidence has shown the potential usefulness of probiotics in the management of oral and vulvovaginal candidiasis in recent years. Among other results, we found that, as for bacterial infections, Lactobacillus, Bifidobacterium, and Saccharomyces are the most studied and effective genus for this purpose. However, in other areas, particularly in skincandidiaisis, studies are low or lacking. Thus, further investigation is necessary including in vitro and in vivo studies to establish the usefulness of probiotics in the management of candidiasis.


Subject(s)
Candidiasis , Probiotics , Female , Humans , Antifungal Agents/pharmacology , Antifungal Agents/therapeutic use , Candidiasis/drug therapy , Candidiasis/prevention & control , Probiotics/therapeutic use , Candida , Lactobacillus
16.
Curr Microbiol ; 79(12): 394, 2022 Nov 03.
Article in English | MEDLINE | ID: mdl-36329335

ABSTRACT

L-asparaginase has prime medical significance due to its chemotherapeutic applications and action against a wide range of diseases. L-asparaginase obtained from commercial producer bacterial strains causes anaphylaxis, some sensitive reactions, and other side effects. To overcome these issues, eukaryotes like fungi can be used to produce L-asparaginase. Penicillium lilacinum was explored for its enhanced production through a statistically optimized fermentation approach. Firstly, the significant fermentation parameters (influencing the production) were screened through the Plackett-Burman approach. Thereafter, Response Surface Methodology (RSM) was employed for achieving higher production of L-asparaginase under specified fermentation conditions. The study explored both submerged (SmF) and solid-state (SSF) fermentation conditions to put forward a comparative analysis of the best suitable fermentation condition for the enhanced production of L-asparaginase. The Plackett-Burman optimization result suggested that pH, L-asparagine, ammonium nitrate, and temperature were significantly affecting enzyme production in SmF conditions, whereas wheat bran, arhar bran, kulthi bran, and temperature were identified as significant process parameters for SSF. The final enzyme activity obtained in SmF was 82.29 IU/mL and 190.439 U/gds in SSF after the implication of RSM. The statistical optimization tool fosters 2.47-fold and 6.36-fold enzyme activity in SmF and SSF, respectively. The study suggested that L-asparaginase can be efficiently produced using P. lilacinum at an optimized SSF condition.


Subject(s)
Asparaginase , Fungi , Asparaginase/metabolism , Fermentation , Fungi/metabolism , Agriculture , Bacteria/metabolism
17.
Drug Dev Ind Pharm ; 48(11): 602-610, 2022 Nov.
Article in English | MEDLINE | ID: mdl-36369943

ABSTRACT

OBJECTIVE: Fabrication and analyses of mucoadhesive patches made from chitosan oligosaccharide for the purpose of oromucosal drug delivery. SIGNIFICANCE: The mucosal epithelium in the oral cavity, consisting of buccal and sublingual epithelium, has gained significant attention in the last decade as an alternative anatomical site for systemic drug delivery that could potentially minimize the challenges of solid oral dosage and parenteral delivery. In this study, we have fabricated and tested drug-loaded chitosan oligosaccharide-based patches for the oromucosal drug delivery. METHODS: The chitosan oligosaccharide (with and without alginate) based patches were fabricated using the conventional solvent casting method and were analyzed for their swelling capacity, hydrophilicity, anti-cancer activity, in vitro drug release, and in vivo drug release activity. The in-house developed artificial saliva was used for the swelling study. RESULTS: Alginate-containing patches showed lesser swelling ability compared to the bare chitosan oligosaccharide-based patches. The former was also found to be more hydrophobic compared to the latter one. Both the unloaded patches restricted the growth of epithelial cancer cells indicating their anti-cancer behavior. In vitro drug release indicated a super case II release pattern while in vivo study demonstrated the release of drug from the patch into the plasma indicating the purpose of the fabricated patch. CONCLUSIONS: The chitosan oligosaccharide-based mucoadhesive hydrogel patch fabricated in this study can be highly suitable for possible translational purposes.


Subject(s)
Chitosan , Chitosan/chemistry , Mouth Mucosa , Drug Delivery Systems/methods , Hydrogels , Oligosaccharides , Alginates
18.
Cell Physiol Biochem ; 55(S2): 49-70, 2021 Mar 27.
Article in English | MEDLINE | ID: mdl-33770426

ABSTRACT

Major cause of proteopathies is the accumulation of unwanted mutant and aberrant proteins. We know that imperfect ageing is one of chief risk factor for most neurodegenerative diseases. Neurodegenerative diseases are characterized by mutant misfolded protein aggregates developing neural stress and debilitating several neuronal processes. Reducing the levels of these abnormal proteins using various natural compounds can be a promising possible therapeutic strategy. But the advancement of natural compound-based therapies in neurodegeneration and imperfect ageing treatment has been impeded by different challenges and unknown molecular patho-mechansim. The complexity in the causative factors generating protein aggregates in neurons and their respective path towards cell death is high, making it a difficult to treat disorder. Several plant based compounds have proven to promote different neuronal homeostasis mechanisms. However, there is a pressing necessity to screen, find and develop cost-effective natural compound-based new therapeutic interventions which can be useful for clinical purposes in treating neurodegenerative ailments. It is critical to discuss and elaborate the applications of few important natural compounds and their connections with following mechanisms: protein disposal machineries, apoptosis, neuroinflammation, neuronal development, synaptogenesis and neural homeostasis. This article summarizes the current knowledge and discusses the unanswered questions linked with the natural compounds and their promising therapeutic avenues primarily focusing on neurodegenerative diseases and defective neurobiological mechanisms.


Subject(s)
Neurodegenerative Diseases/metabolism , Neurodegenerative Diseases/pathology , Neurons/pathology , Proteome/metabolism , Biological Products/pharmacology , Humans , Neurodegenerative Diseases/drug therapy , Neurons/metabolism , Protein Aggregation, Pathological
19.
Cell Physiol Biochem ; 55(S2): 120-143, 2021 Oct 16.
Article in English | MEDLINE | ID: mdl-34655466

ABSTRACT

Cells contain several proteins that routinely fulfill multiple requirements for normal physiological survival. Proteostasis dysfunction is linked with different complex human disorders, like cancer, neuron degeneration, and imperfect aging. The ubiquitin proteasome system (UPS) forms the primary proteostasis mechanism taking part in cytoprotection. Cancer cells are well known to possess enhanced cytoprotective properties, and different UPS elements are implicated to be dysregulated at several stages of tumor progression. Furthermore, many studies have found tumor cells to exhibit higher levels of various UPS components, possibly contributing to their robust endurance. In this article, we have presented different cellular protein quality control strategies, essential for maintaining healthy proteome. Here, we have also discussed key contributions and functions of UPS involved in molecular pathomechanisms for establishing cancer conditions. Along with this, the emerging different therapeutic strategies against defective proteome linked with improper cellular proliferation and cancer progression are also reviewed. UPS performs critical regulatory functions in modulating the cellular apoptotic pathways. The proteasomal system involvement as probable therapeutic targets influencing cancer cell apoptosis is also discussed. Our article summarizes the recent developments in proteasome-associated pathways regulating tumor cell proteome and survival. Additionally, how the engagement and cross functions of these physiological processes can induce apoptosis and may develop regulation over tumor progression. A better understanding of multifaceted protein quality control pathways may inform therapeutic interventions based on cellular proteostasis response determined against complex diseases.


Subject(s)
Cell Proliferation , Neoplasms/metabolism , Proteasome Endopeptidase Complex/metabolism , Animals , Apoptosis/drug effects , Cell Proliferation/drug effects , Humans , Molecular Targeted Therapy , Neoplasms/drug therapy , Neoplasms/pathology , Proteasome Inhibitors/pharmacology , Proteolysis/drug effects , Proteostasis/drug effects , Ubiquitin/metabolism
20.
J Neurosci Res ; 99(7): 1815-1834, 2021 07.
Article in English | MEDLINE | ID: mdl-33819353

ABSTRACT

Rapid eye movement sleep (REMS) favors brain development and memory, while it is decreased in neurodegenerative diseases. REMS deprivation (REMSD) affects several physiological processes including memory consolidation; however, its detailed mechanism(s) of action was unknown. REMS reduces, while REMSD elevates noradrenaline (NA) level in the brain; the latter induces several deficiencies and disorders, including changes in neuronal cytomorphology and apoptosis. Therefore, we proposed that REMS- and REMSD-associated modulation of NA level might affect neuronal plasticity and affect brain functions. Male albino rats were REMS deprived by flower-pot method for 6 days, and its effects were compared with home cage and large platform controls as well as post-REMSD recovered and REMS-deprived prazosin (α1-adrenoceptor antagonist)-treated rats. We observed that REMSD reduced CA1 and CA3 neuronal dendritic length, branching, arborization, and spine density, while length of active zone and expressions of pre- as well as post-synaptic proteins were increased as compared to controls; interestingly, prazosin prevented most of the effects in vivo. Studies on primary culture of neurons from chick embryo brain confirmed that NA at lower concentration(s) induced neuronal branching and arborization, while higher doses were destructive. The findings support our contention that REMSD adversely affects neuronal plasticity, branching, and synaptic scaffold, which explain the underlying cytoarchitectural basis of REMSD-associated patho-physio-behavioral changes. Consolidation of findings of this study along with that of our previous reports suggest that the neuronal disintegration could be due to either withdrawal of direct protective and proliferative role of low dose of NA or indirect effect of high dose of NA or both.


Subject(s)
Hippocampus/physiopathology , Neuronal Plasticity/physiology , Norepinephrine/metabolism , Sleep Deprivation/physiopathology , Animals , Chick Embryo , Male , Neuronal Plasticity/drug effects , Norepinephrine/pharmacology , Rats , Rats, Wistar
SELECTION OF CITATIONS
SEARCH DETAIL